Pharmaceutical compositions containing a combination of anti-chondrogenesisagents are disclosed. Methods of reducing scleral chondrogensis, reducingone or more ocular chondrogenic proteins, reducing inflammation inducedchondrogensis and treating myopia by administering an effective amount ofone or more anti-chondrogensis agents are also provided.The pharmaceutical compositions are useful for treating myopia.